newsfilter
← Latest News
GlobeNewswire·

TCR² Therapeutics to Present at SVB Securities Global Biopharma Conference 2023

CAMBRIDGE, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) -- TCR² Therapeutics Inc. (NASDAQ:TCRR), a clinical-stage cell therapy company with a pipeline of novel T cell therapies for patients suffering from solid tumors, today